{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:59:04Z","timestamp":1790801944948,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"DOI":"10.1007\/s10096-026-05682-3","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:42:07Z","timestamp":1790754127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for infection in NDM-colonized patients and applicability of the Giannella Risk Score"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-840X","authenticated-orcid":false,"given":"O.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"P\u00e9rez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Filgueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Pernas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rivera-Posada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Pasar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Iglesias-Neiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Rodr\u00edguez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"5682_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL et al (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18:318\u2013327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3","journal-title":"Lancet Infect Dis"},{"key":"5682_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010089","volume":"10","author":"M Rivera-Izquierdo","year":"2021","unstructured":"Rivera-Izquierdo M, L\u00e1inez-Ramos-Bossini AJ, Rivera-Izquierdo C, L\u00f3pez-G\u00f3mez J, Fern\u00e1ndez-Mart\u00ednez NF, Redruello-Guerrero P et al (2021) OXA-48 carbapenemase-producing Enterobacterales in Spanish hospitals: an updated comprehensive review on a rising antimicrobial resistance. Antibiotics (Basel) 10:89. https:\/\/doi.org\/10.3390\/antibiotics10010089","journal-title":"Antibiotics (Basel)"},{"key":"5682_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.tim.2011.09.005","volume":"19","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Poirel L, Walsh TR, Livermore DM (2011) The emerging NDM carbapenemases. Trends Microbiol 19:588\u2013595. https:\/\/doi.org\/10.1016\/j.tim.2011.09.005","journal-title":"Trends Microbiol"},{"key":"5682_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1473-3099(11)70056-1","volume":"11","author":"G Cornaglia","year":"2011","unstructured":"Cornaglia G, Giamarellou H, Rossolini GM (2011) Metallo-\u03b2-lactamases: a last frontier for \u03b2-lactams? Lancet Infect Dis 11:381\u201393. https:\/\/doi.org\/10.1016\/S1473-3099(11)70056-1","journal-title":"Lancet Infect Dis"},{"key":"5682_CR5","doi-asserted-by":"publisher","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA (2024) Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciae403","DOI":"10.1093\/cid\/ciae403"},{"key":"5682_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060723","volume":"11","author":"S Karakonstantis","year":"2022","unstructured":"Karakonstantis S, Rousaki M, Kritsotakis EI (2022) Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance. Antibiotics (Basel) 11:723. https:\/\/doi.org\/10.3390\/antibiotics11060723","journal-title":"Antibiotics (Basel)"},{"key":"5682_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00842-25","volume":"70","author":"M Castanheira","year":"2026","unstructured":"Castanheira M, Kimbrough JH, Morgan GM, Karr M, Sader HS (2026) Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-\u03b2-lactamase-producing Enterobacterales. Antimicrob Agents Chemother 70:e0084225. https:\/\/doi.org\/10.1128\/aac.00842-25","journal-title":"Antimicrob Agents Chemother"},{"key":"5682_CR8","unstructured":"rel=noopener>PracticeGuidelines@idsociety.org.\u2009<\u2009p>Pranita D. Tamma* Samuel L Aitken, Robert A Bonomo, Amy J Mathers, David van Duin, Cornelius J Clancy"},{"key":"5682_CR9","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1093\/jac\/dkw272","volume":"71","author":"I Machuca","year":"2016","unstructured":"Machuca I, Guti\u00e9rrez-Guti\u00e9rrez B, P\u00e9rez Cort\u00e9s S, Gracia-Ahufinger I, Serrano J, Madrigal MD et al (2016) Oral decontamination with aminoglycosides is associated with lower risk of mortality and infections in high-risk patients colonized with colistin-resistant, KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother 71:3242\u20139. https:\/\/doi.org\/10.1093\/jac\/dkw272","journal-title":"J Antimicrob Chemother"},{"key":"5682_CR10","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/1469-0691.12747","volume":"20","author":"M Giannella","year":"2014","unstructured":"Giannella M, Trecarichi EM, De Rosa FG, Del Bono V, Bassetti M, Lewis RE et al (2014) Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect 20:1357\u201362. https:\/\/doi.org\/10.1111\/1469-0691.12747","journal-title":"Clin Microbiol Infect"},{"key":"5682_CR11","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/cid\/cix991","volume":"66","author":"A Cano","year":"2018","unstructured":"Cano A, Guti\u00e9rrez-Guti\u00e9rrez B, Machuca I, Gracia-Ahufinger I, P\u00e9rez-Nadales E, Causse M et al (2018) Risks of infection and mortality among patients colonized with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: validation of scores and proposal for management. Clin Infect Dis 66:1204\u201310. https:\/\/doi.org\/10.1093\/cid\/cix991","journal-title":"Clin Infect Dis"},{"key":"5682_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"5682_CR13","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.mayocp.2016.06.024","volume":"91","author":"B Guti\u00e9rrez-Guti\u00e9rrez","year":"2016","unstructured":"Guti\u00e9rrez-Guti\u00e9rrez B, Salamanca E, de Cueto M, Hsueh P-R, Viale P, Pa\u00f1o-Pardo JR et al (2016) A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae. Mayo Clin Proc 91:1362\u201371. https:\/\/doi.org\/10.1016\/j.mayocp.2016.06.024","journal-title":"Mayo Clin Proc"},{"key":"5682_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2026.100545","volume":"8","author":"P Favier","year":"2026","unstructured":"Favier P, Su\u00e1rez-Urquiza P, Raffo C, Torres D, Pinilla-Huayta F, Mu\u00f1oz-Soto C et al (2026) Predictive value of extra-rectal colonization and the Giannella risk score for subsequent carbapenem-resistant Enterobacterales infections in ICU patients: an Argentinean retrospective cohort study in a mixed KPC and NDM setting. Infect Prev Pract 8:100545. https:\/\/doi.org\/10.1016\/j.infpip.2026.100545","journal-title":"Infect Prev Pract"},{"key":"5682_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1473-3099(25)00469-4","volume":"26","author":"DL Paterson","year":"2026","unstructured":"Paterson DL, Sulaiman H, Liu P-Y, Chatfield MD, Yilmaz M, Salmuna ZN et al (2026) Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial. Lancet Infect Dis 26:148\u2013159. https:\/\/doi.org\/10.1016\/S1473-3099(25)00469-4","journal-title":"Lancet Infect Dis"},{"key":"5682_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01217-22","volume":"10","author":"S Wang","year":"2022","unstructured":"Wang S, Ju X, Dong N, Li R, Li Y, Zhang R et al (2022) Emergence of mobilized colistin resistance gene mcr-8.2 in multidrug-resistant Enterobacter cloacae isolated from a patient in China. Microbiol Spectr 10:e0121722. https:\/\/doi.org\/10.1128\/spectrum.01217-22","journal-title":"Microbiol Spectr"},{"key":"5682_CR17","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.2147\/IDR.S364526","volume":"8","author":"G Chowdhury","year":"2022","unstructured":"Chowdhury G, Ramamurthy T, Das B, Ghosh D, Okamoto K, Miyoshi S et al (2022) Characterization of NDM-5 Carbapenemase-Encoding Gene (blaNDM-5) \u2013 Positive Multidrug Resistant Commensal Escherichia coli from Diarrheal Patients. Infect Drug Resist 8:15:3631\u20133642. https:\/\/doi.org\/10.2147\/IDR.S364526","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5682_CR18","doi-asserted-by":"publisher","first-page":"e0061223","DOI":"10.1128\/msphere.00612-23","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Wu X, Wu C, Zhou P, Yang Y, Wang B et al (2024) Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant Klebsiella pneumoniae with high-risk sequence types ST11 and ST15. mSphere 9:e0061223. https:\/\/doi.org\/10.1128\/msphere.00612-23","journal-title":"mSphere"},{"key":"5682_CR19","doi-asserted-by":"publisher","first-page":"102645","DOI":"10.1016\/j.jiph.2024.102645","volume":"18","author":"IA Al-Zahrani","year":"2025","unstructured":"Al-Zahrani IA, Brek TM (2025) Emergence of a blaNDM-5-carrying extensively drug-resistant Enterobacter cloacae ST1718 in Saudi Arabia: Insights from comprehensive genome analysis. J Infect Public Health 18:102645. https:\/\/doi.org\/10.1016\/j.jiph.2024.102645","journal-title":"J Infect Public Health"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05682-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05682-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05682-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:03:02Z","timestamp":1790798582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05682-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":19,"alternative-id":["5682"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05682-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"2 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}